Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Other Accumulated Expenses: 2009-2024

Historic Other Accumulated Expenses for Innoviva (INVA) over the last 15 years, with Jun 2024 value amounting to $17.1 million.

  • Innoviva's Other Accumulated Expenses fell 23.86% to $17.1 million in Q2 2024 from the same period last year, while for Jun 2024 it was $17.1 million, marking a year-over-year decrease of 23.86%. This contributed to the annual value of $19.7 million for FY2023, which is 7.12% down from last year.
  • Innoviva's Other Accumulated Expenses amounted to $17.1 million in Q2 2024, which was down 27.85% from $23.7 million recorded in Q1 2024.
  • Over the past 5 years, Innoviva's Other Accumulated Expenses peaked at $24.9 million during Q1 2023, and registered a low of $734,000 during Q1 2020.
  • For the 3-year period, Innoviva's Other Accumulated Expenses averaged around $19.4 million, with its median value being $20.5 million (2022).
  • As far as peak fluctuations go, Innoviva's Other Accumulated Expenses slumped by 44.01% in 2020, and later skyrocketed by 2,043.00% in 2022.
  • Innoviva's Other Accumulated Expenses (Quarterly) stood at $1.4 million in 2020, then fell by 28.03% to $1.0 million in 2021, then soared by 2,001.78% to $21.2 million in 2022, then decreased by 7.12% to $19.7 million in 2023, then declined by 23.86% to $17.1 million in 2024.
  • Its last three reported values are $17.1 million in Q2 2024, $23.7 million for Q1 2024, and $19.7 million during Q4 2023.